Study Notes on Shigella
SHIGELLA
Introduction
Shigella is a genus named after Japanese microbiologist Kiyoshi Shiga, who isolated the first strain during a dysentery epidemic in Japan in 1896.
The first member was initially identified as Shigella shiga and is now referred to as S. dysenteriae.
Classification
Family: Enterobacteriaceae.
Characteristics of Shigella:
Gram-negative: They do not retain the crystal violet stain used in Gram staining.
Non-motile: Shigella bacteria do not have flagella for movement.
Facultative anaerobe: Capable of anaerobic fermentation as well as aerobic respiration.
Non-sporeforming: They do not form spores under adverse conditions.
Non-capsulated: Shigella species do not produce a protective capsule.
Non-lactose fermenting: Most species do not ferment lactose, with S. sonnei as an exception.
Catalase positive: All except S. dysenteriae type 1 produce catalase; oxidase negative: Shigella is oxidase negative.
Cultural Characteristics
Growth Conditions:
Temperature range: 10-40°C, optimum at 37°C.
Colony Characteristics:
On nutrient agar: colonies are 2 mm in diameter, circular, convex, smooth, and translucent.
On MacConkey agar: colonies are colorless except for S. sonnei, which appears pink due to lactose fermentation.
On Salmonella-Shigella agar: forms colorless colonies.
Selective Media:
Deoxycholate citrate agar and xylose lysin deoxycholate (XLD) agar are useful for isolating Shigella. Notably, Shigella colonies do not have a black center in these mediums, in contrast to Salmonella.
Viability
Death Point: The bacteria can be killed at 56°C for 1 hour or in 1% phenol for 30 minutes.
Survival:
Viable in water and ice for 1 to 6 months.
In feces, they die within a few hours due to the acidity caused by the growth of competing coliform bacteria.
Biochemical Reactions
Key Reactions:
Catalase: Positive except for S. dysenteriae type 1.
Methyl Red (MR): Positive.
Voges-Proskauer (VP): Negative.
Urease: Negative.
Citrate: Negative.
Oxidase: Negative.
Hydrogen Sulfide (H2S): Negative.
Notably, S. sonnei is characterized as a late lactose fermenter.
Classification Based on Biochemical and Antigenic Characteristics
Subgroup A: S. dysenteriae - 15 serotypes.
Subgroup B: S. flexneri - 8 serotypes.
Subgroup C: S. boydii - 19 serotypes.
Subgroup D: S. sonnei - only 1 serotype.
S. dysenteriae is noted as the most serious type, associated with bacillary dysentery due to Shiga toxin.
Virulence Factors
Plasmid Antigens: The plasmids facilitate the transfer of effectors from bacterial cytoplasm to the epithelial cell cytoplasm of the colon.
Invasiveness: Virulent strains of Shigella penetrate the mucosa and epithelial cells of the colon in a non-uniform manner, leading to intracellular multiplication and invasion of adjacent cells. The consequent inflammation contributes to cell death, influenced by the cytotoxic properties of Shiga toxin that disrupt protein synthesis.
Symptoms of Infection: Cellular death and the resultant phagocytic response by the host results in a bloody discharge of mucus and pus, as well as the characteristic shallow ulcers associated with the disease.
Toxins: Shigella produces a variety of toxins, particularly a Shiga toxin which is implicated in neurotoxic, cytotoxic, and enterotoxic activities, responsible for the watery diarrhea seen in infections.
Clinical Symptoms
The disease ranges from asymptomatic to severe bacillary dysentery
Two-stage disease: watery diarrhea changing to dysentery with frequent small stools with blood and mucus, tenesmus, cramps, fever
Early stage:
Watery diarrhoea attributed to the enterotoxic activity of Shiga toxin
Fever attributed to neurotoxic activity of toxin
Process involves:
Ingestion
Non-invasive colonization and cell multiplication
Production of the enterotoxin by the pathogenic bacteria in the small intestine:
Second stage:
Adherence to tissue invasion of large intestine
Typical symptoms of dysentery
Cytotoxic activity of Shiga toxin increases severity
Pathogenesis
Source: Humans act as either cases or carriers.
Mode of Spread: Transmission occurs through contaminated fingers, food, flies, fomites, and also person-to-person contact.
Infective Dose: Only 10-100 viable bacilli are necessary to cause infection.
Concentration of Pathogen: During early/acute infection, there can be 10^3 to 10^9 viable bacilli per gram of stool.
Laboratory Diagnosis
Sample Collection: Fresh stool, mucus flakes, and rectal swabs are typically collected for testing.
Media for Enrichment: Selenite F broth (0.4%) serves as both enrichment and transport media, with incubation for 9-12 hours.
Culture Media: Various media are used including non-selective Bromocresol purple lactose agar, low selective MacConkey agar, and high selective deoxycholate citrate agar, alongside Salmonella-Shigella (SS) agar.
Epidemiology
Reservoir: Humans are the sole reservoir for Shigella.
Transmission: Primary route is the fecal-oral route.
Distribution by Geography: S. flexneri is more common in developing countries, while S. sonnei is predominant in developed countries.
Treatment and Control
Antibiotics: Treatment regimens typically involve:
Ciprofloxacin
Fluoroquinolone
Azithromycin
Pivmecillinam
Ceftriaxone
Control Measures:
Prevent infected individuals from handling food.
Ensure thorough washing of hands after changing infant diapers.
Disinfect surfaces handled by infected individuals.
Restrict infected children from communal swimming areas.
If traveling, consume only boiled or filtered water, peel fruits yourself, and eat only hot meals.
Follow proper food storage practices.
Conclusion
Understanding Shigella’s characteristics, pathogenesis, and control measures is crucial for prevention and treatment of dysentery caused by these bacteria.